Sandholm, J., Lehtimäki, J., Ishizu, T., Velu, S. E., Clark, J., Härkönen, P., . . . Selander, K. S. (2016). Toll-like receptor 9 expression is associated with breast cancer sensitivity to the growth inhibitory effects of bisphosphonates in vitro and in vivo. Oncotarget.

Sandholm, Jouko, et al. "Toll-like Receptor 9 Expression Is Associated With Breast Cancer Sensitivity to the Growth Inhibitory Effects of Bisphosphonates in Vitro and in Vivo." Oncotarget 2016.

Sandholm, Jouko, et al. "Toll-like Receptor 9 Expression Is Associated With Breast Cancer Sensitivity to the Growth Inhibitory Effects of Bisphosphonates in Vitro and in Vivo." Oncotarget 2016.